{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:49:25Z","timestamp":1780656565389,"version":"3.54.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100006334","name":"Uniwersytet Jana Kochanowskiego w Kielcach","doi-asserted-by":"publisher","award":["SUPB.RN.23.249"],"award-info":[{"award-number":["SUPB.RN.23.249"]}],"id":[{"id":"10.13039\/501100006334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006334","name":"Uniwersytet Jana Kochanowskiego w Kielcach","doi-asserted-by":"publisher","award":["SUPB.RN.23.249"],"award-info":[{"award-number":["SUPB.RN.23.249"]}],"id":[{"id":"10.13039\/501100006334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006334","name":"Uniwersytet Jana Kochanowskiego w Kielcach","doi-asserted-by":"publisher","award":["SUPB.RN.23.249"],"award-info":[{"award-number":["SUPB.RN.23.249"]}],"id":[{"id":"10.13039\/501100006334","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Minerstwo Nauki i Szkolnictwa Wy\u017cszego","award":["RID\/SP\/0015\/2024\/01"],"award-info":[{"award-number":["RID\/SP\/0015\/2024\/01"]}]},{"name":"Minerstwo Nauki i Szkolnictwa Wy\u017cszego","award":["RID\/SP\/0015\/2024\/01"],"award-info":[{"award-number":["RID\/SP\/0015\/2024\/01"]}]},{"name":"Minerstwo Nauki i Szkolnictwa Wy\u017cszego","award":["RID\/SP\/0015\/2024\/01"],"award-info":[{"award-number":["RID\/SP\/0015\/2024\/01"]}]},{"name":"Minerstwo Nauki i Szkolnictwa Wy\u017cszego","award":["RID\/SP\/0015\/2024\/01"],"award-info":[{"award-number":["RID\/SP\/0015\/2024\/01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89847-8","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T15:01:58Z","timestamp":1739372518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quinalizarin induces autophagy, apoptosis and mitotic catastrophe in cervical and prostate cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Wojciech","family":"Trybus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Trybus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"Obarzanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodora","family":"Kr\u00f3l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"89847_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"89847_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/cancers12010051","volume":"12","author":"S Saranyutanon","year":"2019","unstructured":"Saranyutanon, S., Srivastava, S. K., Pai, S., Singh, S. & Singh, A. P. Therapies targeted to androgen receptor signaling axis in prostate cancer: Progress, challenges, and hope. Cancers (Basel). 12, 51. https:\/\/doi.org\/10.3390\/cancers12010051 (2019).","journal-title":"Cancers (Basel)"},{"key":"89847_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla, P. Epidemiology of prostate cancer. World J. Oncol. 10, 63\u201389. https:\/\/doi.org\/10.14740\/wjon1191 (2019).","journal-title":"World J. Oncol."},{"key":"89847_CR4","doi-asserted-by":"publisher","first-page":"604214","DOI":"10.3389\/fonc.2020.604214","volume":"10","author":"AA Bahnassy","year":"2020","unstructured":"Bahnassy, A. A., Abdellateif, M. S. & Zekri, A. N. Cancer in Africa: is it a genetic or environmental health problem? Front. Oncol. 10, 604214. https:\/\/doi.org\/10.3389\/fonc.2020.604214 (2020).","journal-title":"Front. Oncol."},{"key":"89847_CR5","doi-asserted-by":"publisher","first-page":"217","DOI":"10.5534\/wjmh.210070","volume":"40","author":"N Hinata","year":"2022","unstructured":"Hinata, N. & Fujisawa, M. Racial differences in prostate cancer characteristics and cancer-specific mortality: an overview. World J. Mens Health. 40, 217\u2013227. https:\/\/doi.org\/10.5534\/wjmh.210070 (2022).","journal-title":"World J. Mens Health"},{"key":"89847_CR6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3390\/curroncol30020178","volume":"30","author":"CV Berenguer","year":"2023","unstructured":"Berenguer, C. V., Pereira, F., Camara, J. S. & Pereira, J. A. M. Underlying features of prostate cancer-statistics, risk factors, and emerging methods for its diagnosis. Curr. Oncol. 30, 2300\u20132321. https:\/\/doi.org\/10.3390\/curroncol30020178 (2023).","journal-title":"Curr. Oncol."},{"key":"89847_CR7","doi-asserted-by":"publisher","unstructured":"Bergengren, O. et al. Update on prostate cancer epidemiology and risk factors\u2014A systematic review. Eur Urol 84, 191\u2013206. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.021 (2023).","DOI":"10.1016\/j.eururo.2023.04.021"},{"key":"89847_CR8","doi-asserted-by":"publisher","unstructured":"Messina, C. et al. BRCA mutations in prostate cancer: prognostic and predictive implications. J. Oncol. 2020, 4986365. https:\/\/doi.org\/10.1155\/2020\/4986365 (2020).","DOI":"10.1155\/2020\/4986365"},{"key":"89847_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrurol.2014.100","volume":"11","author":"C Bach","year":"2014","unstructured":"Bach, C. et al. The status of surgery in the management of high-risk prostate cancer. Nat. Rev. Urol. 11, 342\u2013351. https:\/\/doi.org\/10.1038\/nrurol.2014.100 (2014).","journal-title":"Nat. Rev. Urol."},{"key":"89847_CR10","doi-asserted-by":"publisher","first-page":"730","DOI":"10.3390\/molecules27175730","volume":"27","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha, M. et al. Prostate cancer review: Genetics, diagnosis, treatment options, and alternative approaches. Molecules 27, 730. https:\/\/doi.org\/10.3390\/molecules27175730 (2022).","journal-title":"Molecules"},{"key":"89847_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3390\/cancers14122913","volume":"14","author":"SS Boon","year":"2022","unstructured":"Boon, S. S., Luk, H. Y., Xiao, C., Chen, Z. & Chan, P. K. Review of the standard and advanced screening, staging systems and treatment modalities for cervical cancer. Cancers (Basel). 14, 913. https:\/\/doi.org\/10.3390\/cancers14122913 (2022).","journal-title":"Cancers (Basel)"},{"key":"89847_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3322\/caac.21696","volume":"71","author":"PE Castle","year":"2021","unstructured":"Castle, P. E., Einstein, M. H. & Sahasrabuddhe, V. V. Cervical cancer prevention and control in women living with human immunodeficiency virus. CA Cancer J. Clin. 71, 505\u2013526. https:\/\/doi.org\/10.3322\/caac.21696 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"89847_CR13","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1080\/01443615.2019.1634030","volume":"40","author":"KS Okunade","year":"2020","unstructured":"Okunade, K. S. Human papillomavirus and cervical cancer. J. Obstet. Gynaecol. 40, 602\u2013608. https:\/\/doi.org\/10.1080\/01443615.2019.1634030 (2020).","journal-title":"J. Obstet. Gynaecol."},{"key":"89847_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.gocm.2023.01.001","volume":"3","author":"SJ Pingping","year":"2023","unstructured":"Pingping, S. J. et al. Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesions. Gynecol. Obstet. Clin. Med. 3, 22\u201329. https:\/\/doi.org\/10.1016\/j.gocm.2023.01.001 (2023).","journal-title":"Gynecol. Obstet. Clin. Med."},{"key":"89847_CR15","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","volume":"20","author":"R Hull","year":"2020","unstructured":"Hull, R. et al. Cervical cancer in low and middle-income countries. Oncol. Lett. 20, 2058\u20132074. https:\/\/doi.org\/10.3892\/ol.2020.11754 (2020).","journal-title":"Oncol. Lett."},{"key":"89847_CR16","doi-asserted-by":"publisher","first-page":"899208","DOI":"10.3389\/fphar.2022.899208","volume":"13","author":"ZW Zhou","year":"2022","unstructured":"Zhou, Z. W. et al. Therapeutic effects of natural products on cervical cancer: based on inflammatory pathways. Front. Pharmacol. 13, 899208. https:\/\/doi.org\/10.3389\/fphar.2022.899208 (2022).","journal-title":"Front. Pharmacol."},{"key":"89847_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1200\/JGO.2016.003954","volume":"2","author":"LT Chuang","year":"2016","unstructured":"Chuang, L. T. et al. Management and care of women with invasive cervical cancer: American society of clinical oncology resource-stratified clinical practice guideline. J. Glob Oncol. 2, 311\u2013340. https:\/\/doi.org\/10.1200\/JGO.2016.003954 (2016).","journal-title":"J. Glob Oncol."},{"key":"89847_CR18","doi-asserted-by":"publisher","first-page":"200238","DOI":"10.1016\/j.tvr.2022.200238","volume":"13","author":"CA Burmeister","year":"2022","unstructured":"Burmeister, C. A. et al. Cervical cancer therapies: current challenges and future perspectives. Tumour Virus Res. 13, 200238. https:\/\/doi.org\/10.1016\/j.tvr.2022.200238 (2022).","journal-title":"Tumour Virus Res."},{"key":"89847_CR19","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.rpor.2018.09.002","volume":"23","author":"GO Regalado Porras","year":"2018","unstructured":"Regalado Porras, G. O., Nogueda, C., Poitevin Chacon, A. & J. & Chemotherapy and molecular therapy in cervical cancer. Rep. Pract. Oncol. Radiother. 23, 533\u2013539. https:\/\/doi.org\/10.1016\/j.rpor.2018.09.002 (2018).","journal-title":"Rep. Pract. Oncol. Radiother"},{"key":"89847_CR20","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/molecules27082466","volume":"27","author":"D Tsvetkova","year":"2022","unstructured":"Tsvetkova, D. & Ivanova, S. Application of approved cisplatin derivatives in combination therapy against different cancer diseases. Molecules 27, 466. https:\/\/doi.org\/10.3390\/molecules27082466 (2022).","journal-title":"Molecules"},{"key":"89847_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.4103\/aja.aja_40_17","volume":"20","author":"R Nader","year":"2018","unstructured":"Nader, R., El Amm, J. & Aragon-Ching, J. B. Role of chemotherapy in prostate cancer. Asian J. Androl. 20, 221\u2013229. https:\/\/doi.org\/10.4103\/aja.aja_40_17 (2018).","journal-title":"Asian J. Androl."},{"key":"89847_CR22","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/j.gendis.2022.02.007","volume":"10","author":"U Anand","year":"2023","unstructured":"Anand, U. et al. Cancer chemotherapy and beyond: current status, drug candidates, associated risks and progress in targeted therapeutics. Genes Dis. 10, 1367\u20131401. https:\/\/doi.org\/10.1016\/j.gendis.2022.02.007 (2023).","journal-title":"Genes Dis."},{"key":"89847_CR23","doi-asserted-by":"publisher","first-page":"230","DOI":"10.4103\/0976-500X.119704","volume":"4","author":"A Abidi","year":"2013","unstructured":"Abidi, A. & Cabazitaxel A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects. J. Pharmacol. Pharmacother. 4, 230\u2013237. https:\/\/doi.org\/10.4103\/0976-500X.119704 (2013).","journal-title":"J. Pharmacol. Pharmacother"},{"key":"89847_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3978\/j.issn.2223-4683.2015.04.11","volume":"4","author":"F Recine","year":"2015","unstructured":"Recine, F. & Sternberg, C. N. Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer. Transl Androl. Urol. 4, 355\u2013364. https:\/\/doi.org\/10.3978\/j.issn.2223-4683.2015.04.11 (2015).","journal-title":"Transl Androl. Urol."},{"key":"89847_CR25","doi-asserted-by":"publisher","first-page":"100034","DOI":"10.1016\/j.crphar.2021.100034","volume":"2","author":"S Ghosh","year":"2021","unstructured":"Ghosh, S., Hazra, J., Pal, K., Nelson, V. K. & Pal, M. Prostate cancer: therapeutic prospect with herbal medicine. Curr. Res. Pharmacol. Drug Discov. 2, 100034. https:\/\/doi.org\/10.1016\/j.crphar.2021.100034 (2021).","journal-title":"Curr. Res. Pharmacol. Drug Discov"},{"key":"89847_CR26","doi-asserted-by":"publisher","first-page":"35806","DOI":"10.1039\/d1ra05686g","volume":"11","author":"MS Malik","year":"2021","unstructured":"Malik, M. S. et al. Journey of anthraquinones as anticancer agents\u2014a systematic review of recent literature. RSC Adv. 11, 35806\u201335827. https:\/\/doi.org\/10.1039\/d1ra05686g (2021).","journal-title":"RSC Adv."},{"key":"89847_CR27","doi-asserted-by":"publisher","first-page":"702642","DOI":"10.3389\/fonc.2021.702642","volume":"11","author":"M Gaggianesi","year":"2021","unstructured":"Gaggianesi, M. et al. Messing up the cancer stem cell chemoresistance mechanisms supported by tumor microenvironment. Front. Oncol. 11, 702642. https:\/\/doi.org\/10.3389\/fonc.2021.702642 (2021).","journal-title":"Front. Oncol."},{"key":"89847_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.20517\/cdr.2019.10","volume":"2","author":"X Wang","year":"2019","unstructured":"Wang, X., Zhang, H. & Chen, X. Drug resistance and combating drug resistance in cancer. Cancer Drug Resist. 2, 141\u2013160. https:\/\/doi.org\/10.20517\/cdr.2019.10 (2019).","journal-title":"Cancer Drug Resist."},{"key":"89847_CR29","doi-asserted-by":"publisher","first-page":"114643","DOI":"10.1016\/j.biopha.2023.114643","volume":"162","author":"C Duan","year":"2023","unstructured":"Duan, C. et al. Overcoming cancer multi-drug resistance (MDR): reasons, mechanisms, nanotherapeutic solutions, and challenges. Biomed. Pharmacother. 162, 114643. https:\/\/doi.org\/10.1016\/j.biopha.2023.114643 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"89847_CR30","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3390\/biomedicines9101353","volume":"9","author":"WH Talib","year":"2021","unstructured":"Talib, W. H., Alsayed, A. R., Barakat, M., Abu-Taha, M. I. & Mahmod A. I. Targeting drug chemo-resistance in cancer using natural products. Biomedicines 9, 353. https:\/\/doi.org\/10.3390\/biomedicines9101353 (2021).","journal-title":"Biomedicines"},{"key":"89847_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12964-023-01302-1","volume":"22","author":"SU Khan","year":"2024","unstructured":"Khan, S. U., Fatima, K., Aisha, S. & Malik, F. Unveiling the mechanisms and challenges of cancer drug resistance. Cell. Commun. Signal. 22, 109. https:\/\/doi.org\/10.1186\/s12964-023-01302-1 (2024).","journal-title":"Cell. Commun. Signal."},{"key":"89847_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","volume":"25","author":"AZ Ayob","year":"2018","unstructured":"Ayob, A. Z. & Ramasamy, T. S. Cancer stem cells as key drivers of tumour progression. J. Biomed. Sci. 25, 20. https:\/\/doi.org\/10.1186\/s12929-018-0426-4 (2018).","journal-title":"J. Biomed. Sci."},{"key":"89847_CR33","doi-asserted-by":"publisher","first-page":"842376","DOI":"10.3389\/fphar.2022.842376","volume":"13","author":"GE Chaudhry","year":"2022","unstructured":"Chaudhry, G. E., Md Akim, A., Sung, Y. Y. & Sifzizul, T. M. T. Cancer and apoptosis: the apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics. Front. Pharmacol. 13, 842376. https:\/\/doi.org\/10.3389\/fphar.2022.842376 (2022).","journal-title":"Front. Pharmacol."},{"key":"89847_CR34","doi-asserted-by":"publisher","unstructured":"Xin, D., Li, H., Zhou, S., Zhong, H. & Pu, W. Effects of anthraquinones on immune responses and inflammatory diseases. Molecules 27. https:\/\/doi.org\/10.3390\/molecules27123831 (2022).","DOI":"10.3390\/molecules27123831"},{"key":"89847_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/slct.202204537","volume":"8","author":"DP Raghuveer","year":"2023","unstructured":"Raghuveer, D. P., Murali, V. V. & Nayak, T. S. Exploring anthraquinones as antibacterial and antifungal agents. ChemistrySelect 8, 1\u201316 (2023).","journal-title":"ChemistrySelect"},{"key":"89847_CR36","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s11756-021-01004-4","volume":"77","author":"S Das","year":"2022","unstructured":"Das, S., Singh, A. & Samanta, S. K. Naturally occurring anthraquinones as potential inhibitors of SARS-CoV-2 main protease: an integrated computational study. Biol. (Bratisl). 77, 1121\u20131134. https:\/\/doi.org\/10.1007\/s11756-021-01004-4 (2022).","journal-title":"Biol. (Bratisl)"},{"key":"89847_CR37","doi-asserted-by":"publisher","first-page":"115734","DOI":"10.1016\/j.taap.2021.115734","volume":"431","author":"L Ruan","year":"2021","unstructured":"Ruan, L. et al. Hepatotoxicity or hepatoprotection of emodin? Two sides of the same coin by (1)H-NMR metabolomics profiling. Toxicol. Appl. Pharmacol. 431, 115734. https:\/\/doi.org\/10.1016\/j.taap.2021.115734 (2021).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"89847_CR38","doi-asserted-by":"publisher","unstructured":"Li, X., Chu, S., Liu, Y. & Chen, N. Neuroprotective effects of anthraquinones from rhubarb in central nervous system diseases. Evid. Based Complement. Altern. Med. 2019, 3790728. https:\/\/doi.org\/10.1155\/2019\/3790728 (2019).","DOI":"10.1155\/2019\/3790728"},{"key":"89847_CR39","doi-asserted-by":"publisher","first-page":"13391","DOI":"10.1021\/acsomega.1c01448","volume":"6","author":"NQ Trung","year":"2021","unstructured":"Trung, N. Q. et al. Radical scavenging activity of natural anthraquinones: a theoretical insight. ACS Omega. 6, 13391\u201313397. https:\/\/doi.org\/10.1021\/acsomega.1c01448 (2021).","journal-title":"ACS Omega"},{"key":"89847_CR40","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3390\/ijms19113480","volume":"19","author":"J Marinello","year":"2018","unstructured":"Marinello, J., Delcuratolo, M. & Capranico, G. Anthracyclines as topoisomerase II poisons: from early studies to new perspectives. Int. J. Mol. Sci. 19, 480. https:\/\/doi.org\/10.3390\/ijms19113480 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"89847_CR41","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1002\/jcb.30311","volume":"123","author":"W Trybus","year":"2022","unstructured":"Trybus, W., Krol, T. & Trybus, E. Rhein induces changes in the lysosomal compartment of HeLa cells. J. Cell. Biochem. 123, 1506\u20131524. https:\/\/doi.org\/10.1002\/jcb.30311 (2022).","journal-title":"J. Cell. Biochem."},{"key":"89847_CR42","doi-asserted-by":"publisher","first-page":"110594","DOI":"10.1016\/j.biopha.2020.110594","volume":"131","author":"M Almezgagi","year":"2020","unstructured":"Almezgagi, M. et al. Recent insight into pharmacological activities and molecular pathways. Biomed. Pharmacother. 131, 110594. https:\/\/doi.org\/10.1016\/j.biopha.2020.110594 (2020). Diacerein.","journal-title":"Biomed. Pharmacother"},{"key":"89847_CR43","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.2147\/DDDT.S338548","volume":"15","author":"MN Watroly","year":"2021","unstructured":"Watroly, M. N. et al. Chemistry, biosynthesis, physicochemical and biological properties of rubiadin: a promising natural anthraquinone for new drug discovery and development. Drug Des. Dev. Ther. 15, 4527\u20134549. https:\/\/doi.org\/10.2147\/DDDT.S338548 (2021).","journal-title":"Drug Des. Dev. Ther."},{"key":"89847_CR44","doi-asserted-by":"publisher","first-page":"3273","DOI":"10.22034\/APJCP.2017.18.12.3273","volume":"18","author":"W Trybus","year":"2017","unstructured":"Trybus, W. et al. Aloe-emodin influence on the lysosomal compartment of hela cells. Asian Pac. J. Cancer Prev. 18, 3273\u20133279. https:\/\/doi.org\/10.22034\/APJCP.2017.18.12.3273 (2017).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"89847_CR45","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.21873\/anticanres.12057","volume":"37","author":"W Trybus","year":"2017","unstructured":"Trybus, W. et al. Changes in the lysosomal system of cervical cancer cells induced by emodin action. Anticancer Res. 37, 6087\u20136096. https:\/\/doi.org\/10.21873\/anticanres.12057 (2017).","journal-title":"Anticancer Res."},{"key":"89847_CR46","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/cells10082029","volume":"10","author":"W Trybus","year":"2021","unstructured":"Trybus, W., Krol, T., Trybus, E. & Stachurska, A. Physcion induces potential anticancer effects in cervical cancer cells. Cells 10, 29. https:\/\/doi.org\/10.3390\/cells10082029 (2021).","journal-title":"Cells"},{"key":"89847_CR47","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.21873\/anticanres.12443","volume":"38","author":"W Trybus","year":"2018","unstructured":"Trybus, W. et al. Induction of mitotic catastrophe in human cervical cancer cells after administration of aloe-emodin. Anticancer Res. 38, 2037\u20132044. https:\/\/doi.org\/10.21873\/anticanres.12443 (2018).","journal-title":"Anticancer Res."},{"key":"89847_CR48","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/jcb.29891","volume":"122","author":"W Trybus","year":"2021","unstructured":"Trybus, W., Krol, T., Trybus, E., Stachurska, A. & Krol, G. The potential antitumor effect of chrysophanol in relation to cervical cancer cells. J. Cell. Biochem. 122, 639\u2013652. https:\/\/doi.org\/10.1002\/jcb.29891 (2021).","journal-title":"J. Cell. Biochem."},{"key":"89847_CR49","doi-asserted-by":"publisher","first-page":"679","DOI":"10.21873\/anticanres.13163","volume":"39","author":"W Trybus","year":"2019","unstructured":"Trybus, W. et al. Emodin induces death in human cervical cancer cells through mitotic catastrophe. Anticancer Res. 39, 679\u2013686. https:\/\/doi.org\/10.21873\/anticanres.13163 (2019).","journal-title":"Anticancer Res."},{"key":"89847_CR50","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3390\/ijms23158510","volume":"23","author":"W Trybus","year":"2022","unstructured":"Trybus, W., Trybus, E. & Krol, T. Emodin sensitizes cervical cancer cells to vinblastine by inducing apoptosis and mitotic death. Int. J. Mol. Sci. 23, 510. https:\/\/doi.org\/10.3390\/ijms23158510 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"89847_CR51","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro, B. A. & El-Deiry, W. S. Targeting apoptosis in cancer therapy. Nat. Rev. Clin. Oncol. 17, 395\u2013417. https:\/\/doi.org\/10.1038\/s41571-020-0341-y (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"89847_CR52","doi-asserted-by":"publisher","first-page":"6398","DOI":"10.1038\/onc.2008.307","volume":"27","author":"KW Yip","year":"2008","unstructured":"Yip, K. W. & Reed, J. C. Bcl-2 family proteins and cancer. Oncogene 27, 6398\u20136406. https:\/\/doi.org\/10.1038\/onc.2008.307 (2008).","journal-title":"Oncogene"},{"key":"89847_CR53","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/ijms19020448","volume":"19","author":"CM Pfeffer","year":"2018","unstructured":"Pfeffer, C. M., Singh, A. T. K. & Apoptosis A target for anticancer therapy. Int. J. Mol. Sci. 19, 448. https:\/\/doi.org\/10.3390\/ijms19020448 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"89847_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1756-9966-30-87","volume":"30","author":"RS Wong","year":"2011","unstructured":"Wong, R. S. Apoptosis in cancer: from pathogenesis to treatment. J. Exp. Clin. Cancer Res. 30, 87. https:\/\/doi.org\/10.1186\/1756-9966-30-87 (2011).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"89847_CR55","doi-asserted-by":"publisher","first-page":"150845","DOI":"10.1155\/2014\/150845","volume":"2014","author":"M Hassan","year":"2014","unstructured":"Hassan, M., Watari, H., AbuAlmaaty, A., Ohba, Y. & Sakuragi, N. Apoptosis and molecular targeting therapy in cancer. Biomed. Res. Int. 2014, 150845. https:\/\/doi.org\/10.1155\/2014\/150845 (2014).","journal-title":"Biomed. Res. Int."},{"key":"89847_CR56","doi-asserted-by":"publisher","unstructured":"Mc Gee, M. M. Targeting the mitotic catastrophe signaling pathway in cancer. Mediat. Inflamm. 146282. https:\/\/doi.org\/10.1155\/2015\/146282 (2015).","DOI":"10.1155\/2015\/146282"},{"key":"89847_CR57","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13062-021-00313-7","volume":"16","author":"EV Sazonova","year":"2021","unstructured":"Sazonova, E. V., Petrichuk, S. V., Kopeina, G. S. & Zhivotovsky, B. A link between mitotic defects and mitotic catastrophe: detection and cell fate. Biol. Direct. 16, 25. https:\/\/doi.org\/10.1186\/s13062-021-00313-7 (2021).","journal-title":"Biol. Direct"},{"key":"89847_CR58","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/nrm3115","volume":"12","author":"I Vitale","year":"2011","unstructured":"Vitale, I., Galluzzi, L., Castedo, M. & Kroemer, G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat. Rev. Mol. Cell. Biol. 12, 385\u2013392. https:\/\/doi.org\/10.1038\/nrm3115 (2011).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"89847_CR59","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1054\/drup.2001.0213","volume":"4","author":"IB Roninson","year":"2001","unstructured":"Roninson, I. B., Broude, E. V. & Chang, B. D. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist. Updat. 4, 303\u2013313. https:\/\/doi.org\/10.1054\/drup.2001.0213 (2001).","journal-title":"Drug Resist. Updat"},{"key":"89847_CR60","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00204-019-02623-2","volume":"94","author":"H Li","year":"2020","unstructured":"Li, H. et al. Mitotic catastrophe and p53-dependent senescence induction in T-cell malignancies exposed to nonlethal dosage of GL-V9. Arch. Toxicol. 94, 305\u2013323. https:\/\/doi.org\/10.1007\/s00204-019-02623-2 (2020).","journal-title":"Arch. Toxicol."},{"key":"89847_CR61","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.saa.2007.07.038","volume":"70","author":"C Qiao","year":"2008","unstructured":"Qiao, C. et al. Study of interactions of anthraquinones with DNA using ethidium bromide as a fluorescence probe. Spectrochim Acta Mol. Biomol. Spectrosc. 70, 136\u2013143. https:\/\/doi.org\/10.1016\/j.saa.2007.07.038 (2008).","journal-title":"Spectrochim Acta Mol. Biomol. Spectrosc."},{"key":"89847_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.11.002","volume":"24","author":"TV Denisenko","year":"2016","unstructured":"Denisenko, T. V., Sorokina, I. V., Gogvadze, V. & Zhivotovsky, B. Mitotic catastrophe and cancer drug resistance: a link that must to be broken. Drug Resist. Updat. 24, 1\u201312 (2016).","journal-title":"Drug Resist. Updat"},{"key":"89847_CR63","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1080\/15384101.2020.1716144","volume":"19","author":"LC Husemann","year":"2020","unstructured":"Husemann, L. C. et al. The microtubule targeting agents eribulin and paclitaxel activate similar signaling pathways and induce cell death predominantly in a caspase-independent manner. Cell. Cycle. 19, 464\u2013478. https:\/\/doi.org\/10.1080\/15384101.2020.1716144 (2020).","journal-title":"Cell. Cycle"},{"key":"89847_CR64","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1016\/j.bmcl.2018.06.044","volume":"28","author":"E Martino","year":"2018","unstructured":"Martino, E. et al. Vinca alkaloids and analogues as anti-cancer agents: looking back, peering ahead. Bioorg. Med. Chem. Lett. 28, 2816\u20132826. https:\/\/doi.org\/10.1016\/j.bmcl.2018.06.044 (2018).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"89847_CR65","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1158\/1535-7163.MCT-14-0265","volume":"13","author":"O Azarenko","year":"2014","unstructured":"Azarenko, O., Smiyun, G., Mah, J., Wilson, L. & Jordan, M. A. Antiproliferative mechanism of action of the novel taxane cabazitaxel as compared with the parent compound docetaxel in MCF7 breast cancer cells. Mol. Cancer Ther. 13, 2092\u20132103. https:\/\/doi.org\/10.1158\/1535-7163.MCT-14-0265 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"89847_CR66","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3390\/molecules26216642","volume":"26","author":"P Thongnuanjan","year":"2021","unstructured":"Thongnuanjan, P. et al. Panduratin A derivative protects against cisplatin-induced apoptosis of renal proximal tubular cells and kidney injury in mice. Molecules 26, 642. https:\/\/doi.org\/10.3390\/molecules26216642 (2021).","journal-title":"Molecules"},{"key":"89847_CR67","doi-asserted-by":"publisher","unstructured":"Song, X. L. et al. Casticin induces apoptosis and G0\/G1 cell cycle arrest in gallbladder cancer cells. Cancer Cell. Int. 17. https:\/\/doi.org\/10.1186\/s12935-016-0377-3 (2017).","DOI":"10.1186\/s12935-016-0377-3"},{"key":"89847_CR68","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/biom9090418","volume":"9","author":"K Thangaraj","year":"2019","unstructured":"Thangaraj, K. et al. Orientin induces G0\/G1 cell cycle arrest and mitochondria mediated intrinsic apoptosis in human colorectal carcinoma HT29 cells. Biomolecules 9, 418. https:\/\/doi.org\/10.3390\/biom9090418 (2019).","journal-title":"Biomolecules"},{"key":"89847_CR69","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.21037\/apm-20-288","volume":"10","author":"Y Bian","year":"2021","unstructured":"Bian, Y. et al. Ligustrazine induces the colorectal cancer cells apoptosis via p53-dependent mitochondrial pathway and cell cycle arrest at the G0\/G1 phase. Ann. Palliat. Med. 10, 1578\u20131588. https:\/\/doi.org\/10.21037\/apm-20-288 (2021).","journal-title":"Ann. Palliat. Med."},{"key":"89847_CR70","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1038\/onc.2011.451","volume":"31","author":"RH Medema","year":"2012","unstructured":"Medema, R. H. & Macurek, L. Checkpoint control and cancer. Oncogene 31, 2601\u20132613. https:\/\/doi.org\/10.1038\/onc.2011.451 (2012).","journal-title":"Oncogene"},{"key":"89847_CR71","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.4161\/cbt.8.15.9081","volume":"8","author":"K Kuntz","year":"2009","unstructured":"Kuntz, K. & O\u2019Connell, M. J. The G(2) DNA damage checkpoint: could this ancient regulator be the Achilles heel of cancer? Cancer Biol. Ther. 8, 1433\u20131439. https:\/\/doi.org\/10.4161\/cbt.8.15.9081 (2009).","journal-title":"Cancer Biol. Ther."},{"key":"89847_CR72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.molmed.2010.10.009","volume":"17","author":"CX Ma","year":"2011","unstructured":"Ma, C. X., Janetka, J. W. & Piwnica-Worms, H. Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics. Trends Mol. Med. 17, 88\u201396. https:\/\/doi.org\/10.1016\/j.molmed.2010.10.009 (2011).","journal-title":"Trends Mol. Med."},{"key":"89847_CR73","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3389\/fphar.2012.00009","volume":"3","author":"B Gabrielli","year":"2012","unstructured":"Gabrielli, B., Brooks, K. & Pavey, S. Defective cell cycle checkpoints as targets for anti-cancer therapies. Front. Pharmacol. 3, 9. https:\/\/doi.org\/10.3389\/fphar.2012.00009 (2012).","journal-title":"Front. Pharmacol."},{"key":"89847_CR74","doi-asserted-by":"publisher","unstructured":"Rios, R. M. The centrosome-golgi apparatus nexus. Philos. Trans. R Soc. Lond. B Biol. Sci. 369. https:\/\/doi.org\/10.1098\/rstb.2013.0462 (2014).","DOI":"10.1098\/rstb.2013.0462"},{"key":"89847_CR75","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3389\/fnins.2015.00431","volume":"9","author":"AA Sanders","year":"2015","unstructured":"Sanders, A. A. & Kaverina, I. Nucleation and dynamics of golgi-derived microtubules. Front. Neurosci. 9, 431. https:\/\/doi.org\/10.3389\/fnins.2015.00431 (2015).","journal-title":"Front. Neurosci."},{"key":"89847_CR76","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1631\/jzus.B2100804","volume":"23","author":"Z Bai","year":"2022","unstructured":"Bai, Z. et al. Autophagy and cancer treatment: four functional forms of autophagy and their therapeutic applications. J. Zhejiang Univ. Sci. B. 23, 89\u2013101. https:\/\/doi.org\/10.1631\/jzus.B2100804 (2022).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"89847_CR77","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1158\/0008-5472.CAN-13-2966","volume":"74","author":"DA Gewirtz","year":"2014","unstructured":"Gewirtz, D. A. The four faces of autophagy: implications for cancer therapy. Cancer Res. 74, 647\u2013651. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2966 (2014).","journal-title":"Cancer Res."},{"key":"89847_CR78","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe, M. et al. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14, 1435\u20131455. https:\/\/doi.org\/10.1080\/15548627.2018.1474314 (2018).","journal-title":"Autophagy"},{"key":"89847_CR79","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fphar.2020.00408","volume":"11","author":"T Liu","year":"2020","unstructured":"Liu, T., Zhang, J., Li, K., Deng, L. & Wang, H. Combination of an autophagy inducer and an autophagy inhibitor: a smarter strategy emerging in cancer therapy. Front. Pharmacol. 11, 408. https:\/\/doi.org\/10.3389\/fphar.2020.00408 (2020).","journal-title":"Front. Pharmacol."},{"key":"89847_CR80","doi-asserted-by":"publisher","unstructured":"Pu, Y., Wang, J. & Wang, S. Role of autophagy in drug resistance and regulation of osteosarcoma (review). Mol. Clin. Oncol. 16. https:\/\/doi.org\/10.3892\/mco.2022.2505 (2022).","DOI":"10.3892\/mco.2022.2505"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89847-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89847-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89847-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T15:02:04Z","timestamp":1739372524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89847-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89847"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89847-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"assertion":[{"value":"20 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5252"}}